Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)
China flag China · Delayed Price · Currency is CNY
30.48
+1.51 (5.21%)
Apr 1, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceutical Industry
314.25M236.32M345.00M253.64M175.50M
Pharmaceutical Industry Growth
32.97%-31.50%36.02%44.52%9.41%
Unallocated Other Industries
34.75M33.54M28.88M29.61M24.73M
Unallocated Other Industries Growth
3.63%16.13%-2.48%19.73%20.54%
Total
349.00M269.86M373.88M283.25M200.24M
Total Growth
29.33%-27.82%32.00%41.46%10.67%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
China
323.97M247.41M355.07M270.69M188.31M
China Growth
30.94%-30.32%31.17%43.75%10.58%
Foreign
25.03M22.45M18.81M12.56M11.93M
Foreign Growth
11.52%19.32%49.78%5.29%12.16%
Total
349.00M269.86M373.88M283.25M200.24M
Total Growth
29.33%-27.82%32.00%41.46%10.67%
Source: S&P Global Market Intelligence.